Upcoming Q2 earnings from Moderna, AstraZeneca, GSK and others highlighted in weekly pharma preview
read at Endpoints ↗EarningsNeutral
The Endpoints Weekly newsletter signals a busy earnings week for major pharmaceutical companies, with Q2 results slated from Moderna, AstraZeneca, GSK, Bristol Myers Squibb and several others.
It also mentions that AI firm Anthropic is outlining plans to expand into the life‑science arena, though specific initiatives are not detailed.
The brief further references remarks from the Novartis chief executive regarding partnership opportunities and market activity in China.
Readers are encouraged to subscribe for full access to the articles and to receive future newsletters directly.
source
This writeup was produced by pharmadog from original reporting by Endpoints.
Original headline: “Anthropic’s life science plans; Novartis CEO on China deals; and more”
read at Endpoints ↗86 words · retrieved Jul 25
comments(0)
5-min edit window · permanent after that